Compare, Analyse NUTRAPLUS PR with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NUTRAPLUS PR vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NUTRAPLUS PR   ACTAVIS
EQUITY SHARE DATA
    NUTRAPLUS PR
Mar-20
ACTAVIS
Dec-18
NUTRAPLUS PR/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs2214,588-   
Low Rs59,786-   
Sales per share (Unadj.) Rs25.63,578.4-  
Earnings per share (Unadj.) Rs-14.0-1,152.6-  
Cash flow per share (Unadj.) Rs-12.7377.1-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs6.314,759.3-  
Shares outstanding (eoy) m34.09332.60-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.53.4 15.6%   
Avg P/E ratio x-1.0-10.6 9.2%  
P/CF ratio (eoy) x-1.132.3 -3.3%  
Price / Book Value ratio x2.10.8 260.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m4644,053,328 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m730-   
Avg. sales/employee Rs ThNM70,425.0-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-22,683.9-  
INCOME DATA
Net Sales Rs m8731,190,182 0.1%  
Other income Rs m122,760 0.0%   
Total revenues Rs m8751,212,942 0.1%   
Gross profit Rs m-35831,189 -1.1%  
Depreciation Rs m47508,777 0.0%   
Interest Rs m7468,680 0.1%   
Profit before tax Rs m-478-523,508 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0133,516 0.0%   
Tax Rs m0-6,634 0.0%   
Profit after tax Rs m-478-383,358 0.1%  
Gross profit margin %-41.02.6 -1,565.8%  
Effective tax rate %01.3 0.0%   
Net profit margin %-54.8-32.2 170.0%  
BALANCE SHEET DATA
Current assets Rs m178488,150 0.0%   
Current liabilities Rs m890431,834 0.2%   
Net working cap to sales %-81.54.7 -1,722.6%  
Current ratio x0.21.1 17.7%  
Inventory Days Days120 3.3%  
Debtors Days Days1266 17.4%  
Net fixed assets Rs m939134,722 0.7%   
Share capital Rs m1700-   
"Free" reserves Rs m460-   
Net worth Rs m2164,908,944 0.0%   
Long term debt Rs m21,728,617 0.0%   
Total assets Rs m1,1177,673,797 0.0%  
Interest coverage x-5.4-6.6 82.1%   
Debt to equity ratio x00.4 2.7%  
Sales to assets ratio x0.80.2 504.4%   
Return on assets %-36.2-4.1 882.2%  
Return on equity %-221.3-7.8 2,833.4%  
Return on capital %-185.1-4.8 3,824.5%  
Exports to sales %1.30-   
Imports to sales %0.70-   
Net fx Rs m50-   
CASH FLOW
From Operations Rs m91425,207 0.0%  
From Investments Rs m-27233,596 -0.0%  
From Financial Activity Rs m-76-729,783 0.0%  
Net Cashflow Rs m-12-70,625 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 75.39 Rs / USD

Compare NUTRAPLUS PR With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare NUTRAPLUS PR With: PFIZER  KIMIA BIOSCIENCES  EVEREST ORGANICS  MESCO PHARMA  SAMRAT PHARMA  



Today's Market

Sensex Zooms 800 Points, Nifty Tops 17,400; RBI Keeps Repo Rate Unchanged at 4%(10:30 am)

Asian share markets are higher today after Wall Street shares rallied for a second straight session on receding worries over the latest Covid-19 variant.

Related Views On News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for (Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

6 Penny Stocks that Rallied 1,000%+ in One Year (Views On News)

Dec 6, 2021

These penny stocks shed their penny status by surging 1,000% or more in the last one year.

The Biggest Winners and Losers in India's Transition to Electric Vehicles (Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2022
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: How to Profit from Sensex 100,000
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

NUTRAPLUS PR SHARE PRICE


Dec 6, 2021 (Close)

TRACK NUTRAPLUS PR

  • Track your investment in NUTRAPLUS PR with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NUTRAPLUS PR

NUTRAPLUS PR - RPG LIFE SCIENCES COMPARISON

COMPARE NUTRAPLUS PR WITH

MARKET STATS